Logo image of LON.MI

LONGINO & CARDENAL - SPA (LON.MI) Stock Fundamental Analysis

Europe - BIT:LON - IT0005337073 - Common Stock

1.15 EUR
-0.12 (-9.45%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

3

LON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 53 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of LON is average, but there are quite some concerns on its profitability. LON has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LON has reported negative net income.
In the past year LON had a positive cash flow from operations.
LON had negative earnings in 4 of the past 5 years.
LON had negative operating cash flow in 4 of the past 5 years.
LON.MI Yearly Net Income VS EBIT VS OCF VS FCFLON.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M

1.2 Ratios

LON's Return On Assets of -0.73% is on the low side compared to the rest of the industry. LON is outperformed by 64.15% of its industry peers.
LON has a Return On Equity (-3.35%) which is in line with its industry peers.
LON's Return On Invested Capital of 4.28% is in line compared to the rest of the industry. LON outperforms 49.06% of its industry peers.
Industry RankSector Rank
ROA -0.73%
ROE -3.35%
ROIC 4.28%
ROA(3y)-4.69%
ROA(5y)-3.48%
ROE(3y)-17.5%
ROE(5y)-13.14%
ROIC(3y)N/A
ROIC(5y)N/A
LON.MI Yearly ROA, ROE, ROICLON.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80 100

1.3 Margins

With a Operating Margin value of 1.33%, LON is not doing good in the industry: 64.15% of the companies in the same industry are doing better.
LON's Operating Margin has declined in the last couple of years.
The Gross Margin of LON (17.13%) is worse than 71.70% of its industry peers.
In the last couple of years the Gross Margin of LON has remained more or less at the same level.
Industry RankSector Rank
OM 1.33%
PM (TTM) N/A
GM 17.13%
OM growth 3YN/A
OM growth 5Y-43.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.83%
GM growth 5Y1%
LON.MI Yearly Profit, Operating, Gross MarginsLON.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LON is destroying value.
Compared to 1 year ago, LON has about the same amount of shares outstanding.
The number of shares outstanding for LON remains at a similar level compared to 5 years ago.
Compared to 1 year ago, LON has a worse debt to assets ratio.
LON.MI Yearly Shares OutstandingLON.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
LON.MI Yearly Total Debt VS Total AssetsLON.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 2.38 indicates that LON is not a great score, but indicates only limited risk for bankruptcy at the moment.
LON has a better Altman-Z score (2.38) than 67.92% of its industry peers.
A Debt/Equity ratio of 0.79 indicates that LON is somewhat dependend on debt financing.
LON has a Debt to Equity ratio of 0.79. This is in the better half of the industry: LON outperforms 64.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z 2.38
ROIC/WACC0.73
WACC5.9%
LON.MI Yearly LT Debt VS Equity VS FCFLON.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

2.3 Liquidity

LON has a Current Ratio of 1.29. This is a normal value and indicates that LON is financially healthy and should not expect problems in meeting its short term obligations.
LON's Current ratio of 1.29 is fine compared to the rest of the industry. LON outperforms 79.25% of its industry peers.
LON has a Quick Ratio of 1.03. This is a normal value and indicates that LON is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.03, LON is in the better half of the industry, outperforming 62.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.03
LON.MI Yearly Current Assets VS Current LiabilitesLON.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.81% over the past year.
Looking at the last year, LON shows a quite strong growth in Revenue. The Revenue has grown by 12.81% in the last year.
The Revenue has been growing slightly by 2.23% on average over the past years.
EPS 1Y (TTM)57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.49%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y22.18%
Revenue growth 5Y2.23%
Sales Q2Q%3.6%

3.2 Future

Based on estimates for the next years, LON will show a very strong growth in Earnings Per Share. The EPS will grow by 64.03% on average per year.
Based on estimates for the next years, LON will show a small growth in Revenue. The Revenue will grow by 5.46% on average per year.
EPS Next Y127.27%
EPS Next 2Y104.49%
EPS Next 3Y88.78%
EPS Next 5Y64.03%
Revenue Next Year3.33%
Revenue Next 2Y4.54%
Revenue Next 3Y5.43%
Revenue Next 5Y5.46%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LON.MI Yearly Revenue VS EstimatesLON.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M
LON.MI Yearly EPS VS EstimatesLON.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LON. In the last year negative earnings were reported.
LON is valuated reasonably with a Price/Forward Earnings ratio of 9.49.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LON indicates a rather cheap valuation: LON is cheaper than 92.45% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.86. LON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.49
LON.MI Price Earnings VS Forward Price EarningsLON.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LON is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.29
LON.MI Per share dataLON.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

LON's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LON's earnings are expected to grow with 88.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y104.49%
EPS Next 3Y88.78%

0

5. Dividend

5.1 Amount

No dividends for LON!.
Industry RankSector Rank
Dividend Yield N/A

LONGINO & CARDENAL - SPA

BIT:LON (9/12/2025, 7:00:00 PM)

1.15

-0.12 (-9.45%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.19M
Analysts80
Price Target3.32 (188.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.49
P/S 0.19
P/FCF N/A
P/OCF 20.99
P/B 1.65
P/tB 2.12
EV/EBITDA 12.29
EPS(TTM)-0.02
EYN/A
EPS(NY)0.12
Fwd EY10.54%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.05
OCFY4.77%
SpS5.93
BVpS0.7
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.73%
ROE -3.35%
ROCE 5.71%
ROIC 4.28%
ROICexc 4.97%
ROICexgc 5.71%
OM 1.33%
PM (TTM) N/A
GM 17.13%
FCFM N/A
ROA(3y)-4.69%
ROA(5y)-3.48%
ROE(3y)-17.5%
ROE(5y)-13.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-48.71%
ROICexc growth 3YN/A
ROICexc growth 5Y-48.07%
OM growth 3YN/A
OM growth 5Y-43.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.83%
GM growth 5Y1%
F-Score6
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA 3.02
Cap/Depr 102.19%
Cap/Sales 1.79%
Interest Coverage 250
Cash Conversion 29.97%
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.03
Altman-Z 2.38
F-Score6
WACC5.9%
ROIC/WACC0.73
Cap/Depr(3y)216.35%
Cap/Depr(5y)195.6%
Cap/Sales(3y)4.69%
Cap/Sales(5y)3.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.49%
EPS Next Y127.27%
EPS Next 2Y104.49%
EPS Next 3Y88.78%
EPS Next 5Y64.03%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y22.18%
Revenue growth 5Y2.23%
Sales Q2Q%3.6%
Revenue Next Year3.33%
Revenue Next 2Y4.54%
Revenue Next 3Y5.43%
Revenue Next 5Y5.46%
EBIT growth 1Y107.98%
EBIT growth 3YN/A
EBIT growth 5Y-41.76%
EBIT Next Year934.45%
EBIT Next 3Y172.24%
EBIT Next 5Y93.88%
FCF growth 1Y93.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.04%
OCF growth 3YN/A
OCF growth 5YN/A